Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 11, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 13, 2025
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001903669-25-000006
Filed / recorded
Dec 13, 2025, 12:03 AM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
SPRUCE BIOSCIENCES, INC.
Issuer CIK
1683553
Ticker
SPRB
Reporting person
Javier B. Szwarcberg
Relationship
Director, Officer
Officer title
CHIEF EXECUTIVE OFFICER
Security
Restricted Stock Units
Table
Derivative (Table II)
Transaction date
Dec 11, 2025
Transaction code
A
Shares / units
19,800
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
19,800
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each RSU represents a contingent right to receive one share of SPRB common stock.
25% of the total number of RSUs vested on grant. 25% of the total number of RSUs will vest on December 15, 2026, December 15, 2027 and December 15, 2028, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan) as of each such vesting date. On December 11, 2025, 4,950 shares vested and 2,194 shares were withheld for taxes, resulting in a net issuance of 2,756 shares.